Onco Therapeutics
Published 4 issues per year
ISSN Print: 2694-4642
ISSN Online: 2694-4650
Indexed in
Volume 5, 2014 Issue 3-4
DOI: 10.1615/ForumImmunDisTher.v5.i3-4
Preface: Advances in Molecular Targets for Therapeutics in Resistant Cancers
pp. v-vi
DOI: 10.1615/ForumImmunDisTher.2015014075
Epidemiology, Diagnosis, and Non-Pharmacological Treatment of HCC
pp. 115-136
DOI: 10.1615/ForumImmunDisTher.2015014080
From Targets to Targeted Therapies in Hepatocellular Carcinoma
pp. 145-194
DOI: 10.1615/ForumImmunDisTher.2015013982
Druggable Targets in Pancreatic Adenocarcinoma
pp. 195-214
DOI: 10.1615/ForumImmunDisTher.2015014118
Mechanisms of Raf-1 Kinase Inhibitor Protein Dysregulation in Triple-Negative Breast Cancers and Identification of Possible Novel Therapeutic Approaches for These Tumors
pp. 215-222
DOI: 10.1615/ForumImmunDisTher.2015013936
Targeting PGE2 Signaling in Tumor Progression and Angiogenesis
pp. 223-232
DOI: 10.1615/ForumImmunDisTher.2015014095
Latest Issue
Preface: Phytochemicals for Colorectal Cancer Therapy
Novel and Latest Computational and Development of Anticancer Cancer
Isoquinoline Alkaloids: Promising Natural Compounds for Targeting Angiogenesis and Metastasis in Colon Cancer
Naringenin in the Prevention of Colon Cancer: An Updated Review
Anti-Cancer Pectins and Their Role in Colorectal Cancer Treatment
Citrus Flavones Luteolin and Apigenin Target Fundamental Mechanisms in Colon Cancer
Dietary Phytocompounds for Colon Cancer Therapy
Nano-Formulation for Curcumin and Resveratrol in Colorectal Cancer Therapy